Simurosertib
In Stock•Starting at $64 for 2 mg•Purity ≥ 99%
| CAS No. | 1330782-76-7 |
|---|---|
| MDL No. | N/A |
| MF | C17H19N5OS |
| MW | 341.40 |
| InChI Key | XGVXKJKTISMIOW-ZDUSSCGKSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 2 mg | 99% | $64 | In Stock | |
| 5 mg | 99% | $107 | In Stock | |
| 10 mg | 99% | $174 | In Stock | |
| 25 mg | 99% | $295 | In Stock | |
| 50 mg | 99% | $469 | In Stock |
Product Information
Simurosertib is an orally bioavailable inhibitor of CDC7 (cell division cycle 7-related protein kinase), with potential antineoplastic activity. It binds to and inhibits CDC7, preventing DNA replication initiation during mitosis, leading to cell cycle arrest and apoptosis, thereby inhibiting growth in CDC7-overexpressing tumor cells.
| CAS No. | 1330782-76-7 |
|---|---|
| Product Name | Simurosertib |
Biological Targets
CDC7
Associated Conditions
neoplasm
* The information provided here is compiled from public sources and is for reference only.
